Platify Eltrombopag Tablets 25 mg About
Discover Platify Eltrombopag Tablets 25 mg-an internationally acclaimed, top-rated solution for chronic ITP patients. This first-rate medication, manufactured and supplied from India, is presented in a sturdy blister pack of off-white tablets, guaranteeing optimal integrity and quality. The venerable Platify brand ensures export-quality standards at the lowest price, making effective treatment more accessible. Reduced risk and transcendent performance meet in each allopathic stripe pack. Each box contains 10x1x10 tablets, meticulously formulated to increase platelet count. Prescription required. Store below 30C. Please check the printed expiry date.
Clinical Application and Usage Areas
Platify Eltrombopag Tablets 25 mg are specifically designed for adults suffering from chronic immune thrombocytopenia (ITP). Recommended for oral administration, these off-white tablets act systemically to elevate platelet counts in patients. Their transcendent quality ensures dependable results, making them ideal for hospital, clinic, and at-home care under physician guidance. As an allopathic medication, Platify seamlessly integrates into advanced hematology treatment regimens concerned with the management of thrombocytopenia.
Packaging, Supply, and Efficient Delivery
Each Platify Eltrombopag Tablets pack comprises securely sealed blister stripes, promising product longevity during transit and storage. With robust supply abilities, we streamline logistics ensuring swift, cost-efficient delivery-express shipping options are available to minimize expenditure and meet urgent clinical needs worldwide. Our well-coordinated packaging process maintains the product's integrity, supporting large-scale exports and prompt distribution across international and local markets.
FAQ's of Platify Eltrombopag Tablets 25 mg:
Q: How should Platify Eltrombopag Tablets 25 mg be administered for optimal results?
A: Platify Eltrombopag Tablets 25 mg should be taken orally, exactly as prescribed by your physician. It is important to follow dosage guidelines and not alter the dosage without consulting a medical professional.
Q: What is the primary benefit of using Platify Eltrombopag Tablets 25 mg?
A: The primary benefit of Platify Eltrombopag Tablets is to increase platelet count in adults diagnosed with chronic immune thrombocytopenia (ITP), reducing the risk of bleeding.
Q: When is it appropriate to use Platify Eltrombopag Tablets 25 mg?
A: Platify Eltrombopag Tablets 25 mg are indicated when an adult patient is diagnosed with chronic ITP and requires treatment to raise their platelet levels, as determined by a qualified healthcare provider.
Q: Where is Platify Eltrombopag Tablets 25 mg manufactured and exported from?
A: Platify Eltrombopag Tablets 25 mg are manufactured and exported from India, ensuring international availability and compliance with high export-quality standards.
Q: What is the packaging format and supply process for Platify Eltrombopag Tablets?
A: Platify Eltrombopag Tablets are provided in blister stripe packs, with each box containing 10 x 1 x 10 tablets. The logistics ensure product integrity during express shipping and global distribution.